Prolylproline unit in model peptides and in fragments from databases

Proteins: Structure, Function and Genetics

Volumn 70, Issue 4, 2008, Pages 1389-1407

  Hudáky, Ilona ^a   Perczel, András ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Cis trans isomerism; Inverse turn; Pro pro conformers; Pseudorotation; Ring puckering; turn types I, III, Via, and VIb

Indexed keywords

COLLAGEN; CYCLOPEPTIDE; DNA GLYCOSYLTRANSFERASE; FORMYLPROLYLPROLINAMIDE; PROLINE; THROMBIN; UNCLASSIFIED DRUG;

AB INITIO CALCULATION; AMINO ACID SEQUENCE; ARTICLE; CIS TRANS ISOMERISM; CRYSTAL STRUCTURE; DENSITY FUNCTIONAL THEORY; ENERGY; MODEL; MOTION; POLARIZABLE CONTINUUM MODEL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DATA BANK; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN MOTIF; ROTATION; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 39749164049     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21630     Document Type: Article

References (69)

1. 1 Wilmot CM, Thornton JM. β‐Turns and their distortions: a proposed new nomenclature. Protein Eng 1990 ; 3 (6): 479–493, and references therein.
2. 2 Hudáky I, Gáspári Z, Carugo O, Čemažar M, Pongor S, Perczel A. Vicinal disulfide bridge conformers by experimental methods and by ab initio and DFT molecular computations. Proteins 2004 ; 55: 152–168, and references therein.
3. 3 Karle IL. Conformation of the lithium ion complex of antamanide, a cyclic decapeptide and ion carrier, in the crystalline state. J Am Chem Soc 1974 ; 96: 4000–4006.
4. 4 Di Blasio B, Rossi F, Benedetti E, Pavone V, Pedone C, Temussi PA, Zanotti G, Tancredi T. Bioactive peptides: solid‐state and solution conformation of cyclolinopeptide A. J Am Chem Soc 1989 ; 111: 9089–9098.
5. 5 Morita H, Gonda A, Takeya K, Itokawa H, Hirano T, Oka K, Shirota O. Solution state conformation of an immunosuppressive cyclic dodecapeptide, cycloleonurinin. Tetrahedron 1997 ; 53: 7469–7478.
6. 6 Morita H, Gonda A, Takeya K, Itokawa H, Iitaka Y. Cycloleonuripeptide D, a new proline‐rich cyclic decapeptide from Leonurus heterophyllus. Tetrahedron 1997 ; 53: 1617–1626.
7. 7 Nirthanan S, Gwee MCE. Three‐finger α‐neurotoxins and the nicotonoc acetylcholine receptor, forty years on. J Pharmacol Sci 2004 ; 94: 1–17.
8. 8 Basus VJ, Song G, Hawrot E. NMR solution structure of an α‐bungarotoxin/nicotinic receptor peptide complex. Biochemistry 1993 ; 32: 12290–12298.
9. 9 Love RA, Stroud RM. The crystal structure of alpha‐bungarotoxin at 2.5 Å resolution: relation to solution structure and binding to acetylcholine receptor. Protein Eng 1986 ; 1: 37–46.
10. 10 Samson AO, Scherf T, Eisenstein M, Chill JH, Anglister J. The mechanism for acetylcholine receptor inhibition by α‐neurotoxins and species‐specific resistance to α‐bungarotoxin revealed by NMR. Neuron 2002 ; 35: 319–332.
11. 11 Le Du MH, Marchot P, Bougis PE, Fontecilla‐Camps JC. 1.9‐Å resolution structure of fasciculin‐1, an anti‐acetylcholinesterase toxin from green mamba snake venom. J Biol Chem 1992 ; 267: 22122–22130.
12. 12 Bilwes A, Rees B, Moras D, Ménez R, Ménez A. X‐ray Structure at 1.55 Å of toxin γ, a cardiotoxin from Naja nigricolis venom. J Mol Biol 1994 ; 239: 122–136.
13. 13 O'Connell JF, Bougis PE, Wuthrich K. Determination of the NMR solution structure of cardiotoxin CTX‐IIb from Naja mossambica mossambica. Eur J Biochem 1993 ; 213: 891–900.
14. 14 Zinn‐Justin S, Roumestand C, Gilquin B, Bontems F, Menez A, Toma F. 3‐dimensional solution structure of a curaremimetic toxin from Naja nigricollis venom: a proton NMR and molecular modeling study. Biochemistry 1992 ; 31: 11335–11347.
15. 15 Mitchell SS, Shon KJ, Foster MP, Davis DR, Olivera BM, Ireland CM. Three‐dimensional solution structure of conotoxin ψ‐PIIIE, an acetylcholine gated ion channel antagonist. Biochemistry 1998 ; 37: 1215–1220.
16. 16 Van Wagoner RM, Jacobsen RB, Olivera BM, Ireland CM. Characterization and three‐dimensional solution structure determination of ψ‐conotoxin PIIIF, a novel antagonist of acetylcholine receptors. Biochemistry 2003 ; 42: 6353–6362.
17. 17 Hill JM, Alewood PF, Craik DJ. Solution structure of the sodium channel antagonist conotoxin GS: a new molecular caliper for probing sodium channel geometry. Structure 1997 ; 5: 571–583.
18. 18 Hill JM, Alewood PF, Craik DJ. Conotoxin TVIIA, a novel peptide from the venom of Conus tulipa 2. Three‐dimensional solution structure. Eur J Biochem 2000 ; 267: 4649–4657.
19. 19 Wakamatsu K, Kohda D, Hatanaka H, Lancelin J‐M, Ishida Y, Oya M, Nakamura H, Inagaki F, Sato K. Structure–activity relationships of μ‐conotoxin GIIIA: structure determination of active and inactive sodium channel blocker peptides by NMR and simulated annealing calculations. Biochemistry 1992 ; 31: 12577–12584.
20. 20 Hill JM, Alewood PF, Craik DJ. Three‐dimensional solution structure of μ‐conotoxin GIIIB, a specific blocker of skeletal muscle sodium channels. Biochemistry 1996 ; 35: 8824–8835.
21. 21 Le Bonniec BF, Guinto ER, MacGillivray RTA, Stone ST, Esmon CT. The role of thrombin's Tyr–Pro–Pro–Trp motif in the interaction with fibrinogen, thrombomodulin, protein‐C, antithrombin‐III, and the Kunitz inhibitors. J Biol Chem 1993 ; 268: 19055–11961.
22. 22 Banner DW, Hadváry P. Crystallographic analysis At 3.0‐Å resolution of the binding to human thrombin of four active site‐directed inhibitors. J Biol Chem 1991 ; 266: 20085–20093.
23. 23 Xiao G, Todorova M, Jagadeesh J, Drohat AC, Stivers JT, Gilliland GL. Crystal structure of Escherichia coli uracil DNA glycosylase and its complexes with uracil and glycerol: structure and glycosylase mechanism revisited. Proteins Struct Funct Genetics 1999 ; 35: 13–24.
24. 24 Mol CD, Arvai AS, Sanderson RJ, Slupphaug G, Kavli B, Krokan HE, Mosbaugh DW, Tainer JA. Crystal‐structure of human uracil‐DNA glycosylase in complex with a protein inhibitor—protein mimicry of DNA. Cell 1995 ; 80: 869–878.
25. 25 Savva R, McAuley‐Hecht K, Brown T, Pearl L. The structural basis of specific base‐excision repair by uracil–DNA glycosylase. Nature 1995 ; 373: 487–493.
26. 26 Kay BK, Williamson MP, Sudol M. The importance of being proline: the interaction of proline‐rich motifs in signaling proteins with their cognate domains. FASEB J 2000 ; 14: 231–241.
27. 27 Ogura K, Nagata K, Horiuchi M, Ebisui E, Hasuda T, Yuzawa S, Nishida M, Hatanaka H, Inagaki F. Solution structure of N‐terminal SH3 domain of Vav and the recognition site for Grb2 C‐terminal SH3 domain. J Biomol NMR 2002 ; 22: 37.
28. 28 Vidal M, Goudreau N, Cornille F, Cussac D, Gincel E, Garbay C. Molecular and cellular analysis of Grb2 SH3 domain mutants: interaction with Sos and dynamin. J Mol Biol 1999 ; 290: 717–730.
29. 29 Pisabarro MT, Serrano L, Wilmanns M. Crystal structure of the Abl‐SH3 domain complexed with a designed high‐affinity peptide ligand: implications for SH3‐ligand interactions. J Mol Biol 1998 ; 281: 513–521.
30. 30 Zou P, Pinotsis N, Lange S, Song Y‐H, Popov A, Mavridis I, Mayans OM, Gautel M, Wilmanns M. Palindromic assembly of the giant muscle protein titin in the sarcomeric Z‐disk. Nature 2006 ; 439: 229–233.
31. 31 Atkinson RA, Joseph C, Kelly G, Muskett FW, Frenkiel TA, Nietlispach D, Pastore A. Ca 2+ ‐independent binding of an EF‐hand domain to a novel motif in the α‐actinin–titin complex. Nat Struct Biol 2001 ; 8: 853–857.
32. 32 Buevich AV, Dai Q‐H, Liu X, Brodsky B, Baum J. Site‐Specific NMR Monitoring of cis–trans isomerization in the folding of the proline‐rich collagen triple helix. Biochemistry 2000 ; 39: 4299–4308, and references therein.
33. 33 Kramer RZ, Vitagliano L, Bella J, Berisio R, Mazzarella L, Brodsky B, Zagari A, Berman HM. X‐ray crystallographic determination of a collagen‐like peptide with the repeating sequence (Pro–Pro–Gly). JMol Biol 1998 ; 280: 623–638.
34. 34 Kramer RZ, Bella J, Mayville P, Brodsky B, Berman HM. Sequence dependent conformational variations of collagen triple‐helical structure. Nat Struct Biol 1999 ; 6: 454–457.
35. 35 Linding R, Jensen LJ, Diella F, Bork P, Gibson TJ, Russell RB. Protein disorder prediction: implication for structural proteomics. Structure 2003 ; 11: 1453–1459.
36. 36 Tompa P. The functional benefits of protein disorder. J Mol Struct (THEOCHEM) 2003 ; 666–667: 361–371, and references therein.
37. 37 Baldoni HA, Rodriguez AM, Zamora MA, Zamarbide GN, Enriz RD, Farkas Ö, Császár P, Torday LL, Sosa CP, Jákli I, Perczel A, Papp JG, Hollosi M, Csizmadia IG. Peptide models XXIV: an ab initio study on N ‐formyl‐ L ‐prolinamide with trans peptide bond. The existence or non‐existence of α L and ϵ L conformations. J Mol Struct (THEOCHEM) 1999 ; 465: 79–91.
38. 38 Hudáky I, Baldoni HA, Perczel A. Peptide models XXXVIII. Proline conformers from X‐ray crystallographic database and from ab initio computations. J Mol Struct (THEOCHEM) 2002 ; 582: 233–249.
39. 39 Benzi C, Improta R, Scalmani G, Barone V. Quantum mechanical study of the conformational behavior of proline and 4 R ‐hydroxyproline dipeptide analogues in vacuum and in aqueous solution. J Comput Chem 2002 ; 23: 341–350.
40. 40 Sahai MA, Kehoe TAK, Koo JCP, Setiadi DH, Chass GA, Viskolcz B, Penke B, Pai EF, Csizmadia IG. First principle computational study on the full conformational space of L ‐proline diamides. J Phys Chem A 2005 ; 109: 2660–2679.
41. 41 Oldziej S, Kozlovska U, Liwo A, Scheraga HA. Determination of the potentials of mean force for rotation about C α C α virtual bonds in polypeptides from the ab initio energy surfaces of terminally blocked glycine, alanine, and proline. J Phys Chem 2003 ; 107: 8035–8046.
42. 42 Hudáky I, Kiss R, Perczel A. A nomenclature of peptide conformers. J Mol Struct (THEOCHEM) 2004 ; 675: 177–183.
43. 43 Perczel A, Ángyán JG, Kajtár M, Viviani W, Rivail J‐L, Marcoccia JF, Csizmadia IG. Peptide Models. 1. Topology of selected peptide conformational potential‐energy surfaces (glycine and alanine derivatives). J Am Chem Soc 1991 ; 113: 6256–6265.
44. 44 Hudáky I, Perczel A. Ab initio analysis of the conformational changes of the prolylproline model peptide. J Mol Struct (THEOCHEM) 2003 ; 630: 135–140.
45. 45 Milner‐White EJ, Bell LH, Maccallum PH. Pyrrolidine ring puckering in cis and trans‐proline residues in proteins and polypeptides. J Mol Biol 1992 ; 228: 725–734.
46. 46 Lewis PN, Momany FA, Scheraga HA. Chain reversal in proteins. Biochim Biophys Acta 1973 ; 303: 211–229.
47. 47 Wilmot CM, Thornton JM. β‐Turns and their distortions: a proposed new nomenclature. Protein Eng 1990 ; 3: 479–493.
48. 48 Perczel A, Mcallister MA, Csaszar P, Csizmadia IG. Peptide models 6. New beta‐turn conformations from ab initio calculations confirmed by X‐ray data of proteins. J Am Chem Soc 1993 ; 115: 4849–4858.
49. 49 Perczel A, McAlister MA, Császár P, Csizmadia IG. Peptide models 9. A complete conformational set of For–Ala–Ala–NH 2 from ab inito computations. Can J Chem 1994 ; 72: 2050–2070.
50. 50 Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Zakrzewski VG, Montgomery JA, Stratmann RE, Burant JC, Dapprich S, Millam JM, Daniels AD, Kudin KN, Strain MC, Farkas O, Tomasi J, Barone V, Cossi M, Cammi R, Mennucci B, Pomelli C, Adamo C, Clifford S, Ochterski J, Petersson GA, Ayala PY, Cui Q, Morokuma K, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Cioslowski J, Ortiz JV, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Gomperts R, Martin RL, Fox DJ, Keith T, Al‐Laham MA, Peng CY, Nanayakkara A, Gonzalez C, Challacombe M, Gill PMW, Johnson BG, Chen W, Wong MW, Andres JL, Head‐Gordon M, Replogle ES Pople JA. Gaussian 98, Revision A.1. Pittsburgh PA: Gaussian, Inc. ; 1998.
51. 51 Pulay P. Convergence acceleration of iterative sequences—the case of SCF iteration. Chem Phys Lett 1980 ; 73: 393–398.
52. 52 Pulay P. Improved SCF convergence acceleration. J Comput Chem 1982 ; 3: 556–560.
53. 53 Császár P, Pulay P. Geometry optimization by direct inversion in the iterative subspace. J Mol Struct (THEOCHEM) 1984 ; 114: 31–34.
54. 54 Farkas Ö, Schlegel B. Methods for optimizing large molecules—Part III. An improved algorithm for geometry optimization using direct inversion in the iterative subspace (GDIIS). Phys Chem Chem Phys Lett 2002 ; 4: 11–15.
55. 55 Allen FH. The Cambridge Structural Database: a quarter of a million crystal structures and rising. Acta Crystallogr B 2002 ; 58: 380–388.
56. 56 http://www.chem.qmw.ac.uk/iupac/misc/ppep1.html.
57. 57 Hobohm U, Sander C. Enlarged representative set of protein structures. Protein Sci 1994 ; 3: 522–524.
58. 58 MacArthur MW, Thornton JM. Influence of proline residues on protein conformation. J Mol Biol 1991 ; 218: 397–412.
59. 59 Ho BK, Brasseur R. The Ramachandran plots of glycine and pre‐proline. BMC Struct Biol 2005 ; 5: 14, and references therein.
60. 60 Thomas KM, Naduthambi D, Zondlo NJ. Electronic control of amide cis–trans isomerism via aromatic‐prolyl interaction. J Am Chem Soc 2006 ; 128: 2216–2217.
61. 61 Meng HY, Thomas KM, Lee AE, Zondlo NJ. Effects of i and i +3 residue identity on cis–trans isomerism of the aromatic i +1–prolyl i +2 amide bond: implications for type VI β‐turn formation. Biopolymers 2006 ; 84: 192–204.
62. 62 Hudáky I, Hudáky P, Perczel A. Solvation model induced structural changes in peptides. A quantum chemical study on Ramachandran surfaces and conformers of alanine diamide using the polarizable continuum model. J Comput Chem 2004 ; 25: 1522–1531.
63. 63 Czugler M, Sasvári K, Hollósi M. Crystal structure of cyclo‐(Gly–L ‐Pro–L ‐Pro–Gly–L ‐Pro–L ‐Pro) trihydrate. Unusual conformational characteristics of a cyclic hexapeptide. J Am Chem Soc 1982 ; 104: 4465–4469.
64. 64 Fuess H, Bats J.W. Am Cryst Assoc, Abstr Papers (Summer), 1983 ; 29.
65. 65 Nakashima T, Yamane T, Tanaka I, Ashida T. Structure of cyclo(–L ‐Pro–L ‐Pro–Gly–L ‐Pro–L ‐Leu–Gly–) methanol molvate monohydrate, C 25 H 38 N 6 O 6.CH 3 OH.H 2 O. Acta Crystallogr C 1984 ; 40: 171–174.
66. 66 Perczel A, Jákli I, McAllister MA, Csizmadia I.G. Relative stability of major types of beta‐turns as a function of amino acid composition: a study based on ab initio energetic and natural abundance data. Chem‐Eur J 2003 ; 9: 2551–2566.
67. 67 Adzhubei AA, Sternberg MJE. Left‐handed polyproline II helices commonly occur in globular proteins. J Mol Biol 1993 ; 229: 472–493.
68. 68 Kakinoki S, Hirano Y, Oka M. On the stability of polyproline‐I and II structures of proline oligopeptides. Polym Bull 2005 ; 53: 109–115.
69. 69 Vitagliano L, Berisio R, Mazzarella L, Zagari A. Structural bases of collagen stabilization induced by proline hydroxilation. Biopolymers 2001 ; 58: 459–464.